Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular ‘Direct‐to‐Biology’ Screening
Angewandte Chemie International Edition · 03.02.2025 · 64 (6)
DOI: 10.1002/anie.202418314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 10.12.2024. Verfasst von Harry Wilders und 12 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology, GSK, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus 3C Proteases, Drug Discovery, Protease Inhibitors. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Cancer Research UK, Medical Research Council.
Abstract (Originalsprache)
Reactive fragment (RF) screening has emerged as an efficient method for ligand discovery across the proteome, irrespective of a target's perceived tractability. To date, however, the efficiency of subsequent optimisation campaigns has largely been low‐throughput, constrained by the need for synthesis and purification of target compounds. We report an efficient platform for ‘direct‐to‐biology’ (D2B) screening of cysteine‐targeting chloroacetamide RFs, wherein synthesis is performed in 384‐well plates allowing direct assessment in downstream biological assays without purification. Here, the developed platform was used to optimise inhibitors of SARS‐CoV‐2 main protease (M Pro ), an established drug target for the treatment of COVID‐19. An initial RF hit was developed into a series of potent inhibitors, and further exploration using D2B screening enabled a ‘switch’ to a reversible inhibitor series. This example of ligand discovery for M Pro illustrates the acceleration that D2B chemistry can offer for optimising RFs towards covalent inhibitor candidates, as well as providing future impetus to explore the evolution of RFs into non‐covalent ligands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Biology, GSK, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
- Crick-GSK Biomedical Linklabs, GSK, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
- Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK.
- Screening, Profiling and Mechanistic Biology, GSK, 1250 South Collegeville Road, Collegevill, PA, 19426, US.
- Proteomics Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
ORCID-Profile: Harry Wilders, George Biggs, Sam M Rowe, Emma E Cawood, Ioannis G Riziotis, Alan R Rendina, Jonathan Pettinger, David J Fallon, Mark Skehel, David House, Nicholas C O Tomkinson, Jacob T Bush
Förderung
- Engineering and Physical Sciences Research Council
- Cancer Research UK
- Medical Research Council
- Wellcome Trust
Zitieren
APA
Wilders, H., Biggs, G., Rowe, S. M., Cawood, E. E., Riziotis, I. G., Rendina, A. R., Grant, E. K., Pettinger, J., Fallon, D. J., Skehel, M., House, D., Tomkinson, N. C. O., & Bush, J. T. (2025). Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular ‘Direct‐to‐Biology’ Screening. Angewandte Chemie International Edition, 64(6). https://doi.org/10.1002/anie.202418314
Vancouver
Wilders H, Biggs G, Rowe SM, Cawood EE, Riziotis IG, Rendina AR, et al. Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular ‘Direct‐to‐Biology’ Screening. Angewandte Chemie International Edition. 2025;64(6). doi:10.1002/anie.202418314
BibTeX
@article{Wilders2025,
author = {Wilders, Harry and Biggs, George and Rowe, Sam M and Cawood, Emma E and Riziotis, Ioannis G and Rendina, Alan R and Grant, Emma K and Pettinger, Jonathan and Fallon, David J and Skehel, Mark and House, David and Tomkinson, Nicholas C O and Bush, Jacob T},
title = {Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular ‘Direct‐to‐Biology’ Screening},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {6},
doi = {10.1002/anie.202418314}
}
EUVIMED